WINT
Windtree Therapeutics, Inc. · Healthcare
Bioengine Capital Inc. bought $400K of Windtree Therapeutics, Inc.
10% owner
Bought$399,997
$7.25Price
55,172Shares
−100%Stake
What WINT did for a copier
- $1,000 copied at Mon, Jan 10 close, $63000.00
- $721
- S&P 500, same days
- −9.4%
Measured over 30 trading days, to the Feb 23 close.
Bioengine Capital Inc.'s record
No other buys on record. A record shows here once 3 buys have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, May 20. Filed Mon, Jan 10, 12:03 PM ET, during the session. Returns use the Jan 10 close and the Feb 23 close. Not investment advice.